SANTA CLARA, Calif. & AUSTIN, Texas--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ: AFFX) and Luminex Corporation (NASDAQ: LMNX) today announced a distribution agreement under which eBioscience, a business ...

Luminex Corporation has announced the immediate availability of the Luminex 200, the advancement of Luminex's line of microsphere-based multiplexed detection instruments based on the Company's ...

The speed efficient technology will lead to cost savings that will help it keep its commissions among the lowest in the industry, Luminex said. US-based buy-side owned block trading platform Luminex ...

Neuropore Therapies is discovering and developing novel small molecule disease-modifying therapeutics to treat patients with neurodegenerative diseases, including Parkinson’s disease and Amyotrophic ...

This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. This upgrade has helped make January 2018 Luminex’s best-ever month by ...

The in vitro diagnostics market has grown significantly in the past year, according to a recent report from PricewaterhouseCoopers, and will continue to do so well into the decade. Companies poised to ...